KREBS BIOCHEMICALS & INDUSTRIES
Back to Balance Sheet
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹9.26 Cr | ₹9.26 Cr | ₹9.26 Cr | ₹5.63 Cr | ₹5.55 Cr |
What is the latest Contingent Liabilities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹9.26 Cr |
| Mar2025 | ₹9.26 Cr |
| Mar2024 | ₹9.26 Cr |
| Mar2023 | ₹5.63 Cr |
| Mar2022 | ₹5.55 Cr |
How is Contingent Liabilities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹9.26 Cr | 0.00 | |
| Mar2025 | ₹9.26 Cr | 0.00 | |
| Mar2024 | ₹9.26 Cr | 64.31 | |
| Mar2023 | ₹5.63 Cr | 1.51 | |
| Mar2022 | ₹5.55 Cr | - | |
Compare Contingent Liabilities of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹130.2 Cr | 5.8% | 13.2% | -23.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | 5.8% |
13.2% |
-23.3% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses